CME Information
Provider Statement: This continuing medical education activity is provided by 
Support Statement: This activity is supported by an educational grant from Roche.
Target Audience: The intended audience for this activity is neurologists and other health care professionals involved in the treatment of patients with MS.
Learning Objectives:
Upon successful completion of this educational activity, participants should be better able to:
- Describe current theories and evidence regarding the immunopathogenesis of multiple sclerosis to better understand how new and emerging therapies may target immunological pathways.
- Assess the mechanisms of action, safety, and efficacy of new therapeutic agents for the treatment of multiple sclerosis.
- Apply best practices and clinical evidence when using selective high-efficacy agents to treat relapsing remitting multiple sclerosis to aid in reducing the progression of disease.
Activity Chair:
Prof. Hans-Peter Hartung, MD, FRCP, FAAN, FANA
Professor and Chairman
Department of Neurology
Heinrich-Heine-Universität Düsseldorf
Düsseldorf, Germany
Faculty:
Giancarlo Comi, MD
Professor of Neurology
Director, Department of Neurology
Vita-Salute San Raffaele University
Milan, Italy
Stephen L. Hauser, MD
Director, UCSF Weill Institute for Neurosciences
Professor and Chair, Department of Neurology
University of California, San Francisco
San Francisco, CA
Prof. Xavier Montalban, MD, PhD
Chairman, Dept. of Neurology-Neuroimmunology
Director, Multiple Sclerosis Centre of Catalonia
Vall d’Hebron University Hospital
Barcelona, Spain
Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 1/29/2018)
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair, Planning Committee, and Faculty Members report the following relationship(s) which are accurate at the time of original content release (2/20/2017):
Prof. Hans-Peter Hartung, MD, FRCP, FAAN, FANA
Consulting Fee: Bayer, Biogen, CSL Behring, GeNeuro, Genzyme, MedImmune, Merck Serono, Novartis, Octapharma, Roche
Patricia K. Coyle, MD, FAAN, FANA
Consulting Fee: Accordant, Bayer, Biogen, Genentech/Roche, Mallinckrodt, Novartis, Sanofi-Genzyme, Serono
Contracted Research: Actelion, Genentech/Roche, Novartis, Opexa
Giancarlo Comi, MD
Consulting Fee: Almirall, Biogen, Excemed, Forward Pharma, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva
Non-CME Services Fees: Almirall, Biogen, Excemed, Forward Pharma, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva
Contracted Reasearch: Biogen, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva
Stephen L. Hauser, MD
Scientific Advisory Board: Annexon, Bionure, Molecular Stethoscope, Symbiotix
Board of Trustees: Neurona
Prof. Xavier Montalban, MD, PhD
Consulting Fee: Almirall, Bayer, Biogen, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi-Genzyme, Teva
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was originally approved for 1 year from the date of original release, February 20, 2017 to February 19, 2018. It has since been recertified for an additional year and will now expire on January 29, 2019.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch the presentations, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com